+ All Categories
Home > Documents > Gastric plasmablastic lymphoma in HIV-negative...

Gastric plasmablastic lymphoma in HIV-negative...

Date post: 27-Dec-2019
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
2
CASE REPORT An 82-year-old female patient presented with melena, epi- gastric pain, progressive abdomen fullness and weight loss (8 kg) in the past 2 months. During physical examination, cutaneous pallor was evident and a large abdominal mass in epigastrium was palpable. There was no peripheric lym- phadenopathy or hepatosplenomegaly. Blood count showed microcytic anemia and ferropenia (Hb = 7.5 g/dl, VGM = 79 fL; ferritin = 21 g/l, iron saturation = 23 %). Differential leukocyte counts, hepatic transaminase and lactate dehydrogenate levels were within normal limits. Upper gastrointestinal endoscopy revealed large gastric body ulceration with areas of mucosal hyperemia and pallor (Fig. 1). Computed tomography of the abdomen (Fig. 2) showed diffuse wall thickening involving the gastric fundus, body and antrum. Histological examination of the biopsy specimens revealed a diffuse, monomorphous proliferation of the tumour cells with features of immunoblasts, CD138, MUM-1, and kappa light chains positive (Fig. 3). These plasmablast-like features of tumour cells and lack of CD45 and B-cell associated anti- gens, disclosed the diagnosis of plasmablastic lymphoma (PBL). Serology was negative for the human immunodeficiency virus (HIV), the electrophoretic pattern of serum proteins was normal and the bone marrow biopsy was free of lymphoma at histological evaluation. The patient started treatment with CHOP (cyclophos- phamide, doxorubicin, vincristine, and prednisone) chemother- apy, but died before the second cycle was given. DISCUSSION PBL is a very aggressive variant of diffuse large B-cell lymphoma initially described in the oral cavity of HIV-infect- ed individuals (1). However, recent reports have descri- bed this neoplasm in seronegative and imunocompetent Gastric plasmablastic lymphoma in HIV-negative patient Inês Marques, Ana Lagos and Beatriz Costa-Neves Gastroenterology Department. Hospital Pulido Valente. Lisbon, Portugal 1130-0108/2013/105/3/166-167 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright © 2013 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol. 105. N.° 3, pp. 166-167, 2013 PICTURES IN DIGESTIVE PATHOLOGY Fig. 1. Upper gastrointestinal endoscopy: large gastric body ulceration with areas of mucosal hyperemia and pallor. Fig. 2. Computed tomography of the abdomen: diffuse wall thickening involving the gastric fundus, body and antrum.
Transcript
Page 1: Gastric plasmablastic lymphoma in HIV-negative patientscielo.isciii.es/pdf/diges/v105n3/imagenes2.pdf · PBL is a very aggressive variant of diffuse large B-cell lymphoma initially

CASE REPORT

An 82-year-old female patient presented with melena, epi-gastric pain, progressive abdomen fullness and weight loss(8 kg) in the past 2 months. During physical examination,cutaneous pallor was evident and a large abdominal mass inepigastrium was palpable. There was no peripheric lym-phadenopathy or hepatosplenomegaly.Blood count showed microcytic anemia and ferropenia (Hb= 7.5 g/dl, VGM = 79 fL; ferritin = 21 g/l, iron saturation =23 %). Differential leukocyte counts, hepatic transaminaseand lactate dehydrogenate levels were within normal limits.

Upper gastrointestinal endoscopy revealed large gastricbody ulceration with areas of mucosal hyperemia and pallor(Fig. 1). Computed tomography of the abdomen (Fig. 2)showed diffuse wall thickening involving the gastric fundus,body and antrum.

Histological examination of the biopsy specimens revealeda diffuse, monomorphous proliferation of the tumour cellswith features of immunoblasts, CD138, MUM-1, and kappalight chains positive (Fig. 3). These plasmablast-like featuresof tumour cells and lack of CD45 and B-cell associated anti-gens, disclosed the diagnosis of plasmablastic lymphoma(PBL).

Serology was negative for the human immunodeficiencyvirus (HIV), the electrophoretic pattern of serum proteins wasnormal and the bone marrow biopsy was free of lymphomaat histological evaluation.

The patient started treatment with CHOP (cyclophos-phamide, doxorubicin, vincristine, and prednisone) chemother-apy, but died before the second cycle was given.

DISCUSSION

PBL is a very aggressive variant of diffuse large B-celllymphoma initially described in the oral cavity of HIV-infect-ed individuals (1). However, recent reports have descri -bed this neoplasm in seronegative and imunocompetent

Gastric plasmablastic lymphoma in HIV-negative patient

Inês Marques, Ana Lagos and Beatriz Costa-Neves

Gastroenterology Department. Hospital Pulido Valente. Lisbon, Portugal

1130-0108/2013/105/3/166-167REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVASCopyright © 2013 ARÁN EDICIONES, S. L.

REV ESP ENFERM DIG (Madrid)Vol. 105. N.° 3, pp. 166-167, 2013

PICTURES IN DIGESTIVE PATHOLOGY

Fig. 1. Upper gastrointestinal endoscopy: large gastric body ulcerationwith areas of mucosal hyperemia and pallor.

Fig. 2. Computed tomography of the abdomen: diffuse wall thickeninginvolving the gastric fundus, body and antrum.

Page 2: Gastric plasmablastic lymphoma in HIV-negative patientscielo.isciii.es/pdf/diges/v105n3/imagenes2.pdf · PBL is a very aggressive variant of diffuse large B-cell lymphoma initially

Vol. 105. N.° 3, 2013 GASTRIC PLASMABLASTIC LYMPHOMA IN HIV-NEGATIVE PATIENT 167

REV ESP ENFERM DIG 2013; 105 (3): 166-167

individuals (2) occurring in several other sites, includingthe gastrointestinal tract (2).

PBLs are diffuse large-cell tumours composed by plas-mablast-like cells which lack CD20 and CD45, and dif-fusely express plasma cell-associated antigens (1). Biopsy,with accurate pathological and immunohistological testingand a high level of clinical suspicion are the cornerstonefor correct diagnosis.

The prognosis of PBL is poor and intensive chemother-apy regimens do not seem to increase survival (3).

REFERENCES

1. Delecluse H, Anagnostopoulos I, Dallenbach F, Hummel M, MarafiotiT, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: Anew entity associated with the human immunodeficiency virus infection.Blood 1997;89:1413-20.

2. Castillo J, Pantanowitz L, Dezube B. HIV-associated plasmablasticlymphoma: Lessons learned from 112 published cases. Am J Hematol2008;83:804-9.

3. Castillo J, Furman M, Beltrán B, Bibas M, Bower M, Chen W, et al.Human immunodeficiency virus-associated plasmablastic lymphoma:Poor prognosis in the era of highly active antiretroviral therapy. Can-cer 2012; doi: 10.1002/cncr.27551.

Fig. 3. A. Haematoxylin and eosin section shows large atypical cells with abundant cytoplasm, round nuclei, and occasional centrally located nucleoli(magnification 40×). B. Lack of CD45 antigen. C. D. E. In-situ hybridisation for CD138, MUM and immunoglobulin kappa is strongly positive in neoplasticcells. F. The proliferation index (assessed by Ki-67 stain) is approximately 90 %.


Recommended